Regeneron Pharmaceuticals (REGN)
Other Income/Expenses (Net)
$107.30M
Quarterly · Period ending: · USD
REGN Other Income/Expenses (Net)
Latest reported$107.30Mperiod ending
Latest reported$107.30Mperiod ending
REGN Quarterly Other Income/Expenses (Net) ($0.00 → $107.30M)
Quarterly Other Income/Expenses (Net)
High-resolution chart · PNG
REGN other income/expenses (net) history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Other Income/Expenses (Net) (USD) |
|---|---|
| 107,300,000 | |
| 188,300,000 | |
| 163,800,000 | |
| 736,500,000 | |
| 439,200,000 | |
| 313,300,000 | |
| -32,100,000 | |
| 313,500,000 | |
| 558,500,000 | |
| -50,700,000 | |
| 96,900,000 | |
| -100,200,000 | |
| 66,400,000 | |
| -144,800,000 | |
| 9,300,000 | |
| 286,100,000 | |
| -343,700,000 | |
| -225,500,000 | |
| -136,300,000 | |
| -30,600,000 | |
| 405,600,000 | |
| 140,300,000 | |
| 57,600,000 | |
| -54,799,999 | |
| 262,500,000 | |
| -31,500,000 | |
| 214,100,000 | |
| 30,000,000 | |
| -90,900,000 | |
| 66,100,000 | |
| -41,900,000 | |
| 8,938,000 | |
| 33,886,000 | |
| 18,167,000 | |
| 15,956,000 | |
| 5,679,000 | |
| -24,462,000 | |
| 1,747,000 | |
| -5,476,000 | |
| 3,079,000 | |
| 628,000 | |
| 843,000 | |
| -3,793,000 | |
| 867,000 | |
| -16,863,000 | |
| -7,030,000 | |
| -26,080,000 | |
| -6,641,000 | |
| -19,287,000 | |
| -10,676,000 | |
| -13,920,000 | |
| -11,118,000 | |
| -10,411,000 | |
| -11,219,000 | |
| -11,111,000 | |
| -10,896,000 | |
| -13,535,000 | |
| -10,550,000 | |
| -8,656,000 | |
| -3,346,000 | |
| -3,049,000 | |
| -2,682,000 | |
| 2,751,000 | |
| -1,781,000 | |
| -1,750,000 | |
| -1,645,000 | |
| -1,203,000 | |
| 276,000 | |
| 1,328,000 | |
| 1,750,000 | |
| 2,353,000 | |
| 1,895,000 | |
| 19,619,000 | |
| 15,911,000 | |
| -10,570,000 | |
| 2,829,000 | |
| 3,830,000 | |
| 3,732,000 | |
| -69,664,000 | |
| 847,000 | |
| 673,000 | |
| 42,043,000 | |
| -11,393,000 | |
| 69,039,000 | |
| 59,166,000 | |
| 0 | |
| -10,343,000 | |
| 20,555,000 | |
| 27,192,000 | |
| 40,738,000 | |
| -3,594,000 | |
| 25,703,000 | |
| 55,668,000 | |
| 58,489,000 | |
| -5,640,000 | |
| 32,177,000 | |
| 29,950,000 | |
| 25,193,000 | |
| -6,357,000 | |
| 23,294,000 |